On Tuesday, Larimar Therapeutics Inc (NASDAQ: LRMR) opened lower -4.59% from the last session, before settling in for the closing price of $3.92. Price fluctuations for LRMR have ranged from $1.61 to $5.37 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 50.78%. Company’s average yearly earnings per share was noted -48.77% at the time writing. With a float of $47.71 million, this company’s outstanding shares have now reached $85.59 million.
Larimar Therapeutics Inc (LRMR) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Larimar Therapeutics Inc is 44.26%, while institutional ownership is 57.37%. The most recent insider transaction that took place on Jul 31 ’25, was worth 30,000,000. In this transaction Director of this company bought 9,375,000 shares at a rate of $3.20, taking the stock ownership to the 9,538,945 shares.
Larimar Therapeutics Inc (LRMR) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.45 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.32) by -0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.46 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -48.77% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -6.92% during the next five years compared to 50.78% growth over the previous five years of trading.
Larimar Therapeutics Inc (NASDAQ: LRMR) Trading Performance Indicators
Check out the current performance indicators for Larimar Therapeutics Inc (LRMR). In the past quarter, the stock posted a quick ratio of 4.06. For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.93, a number that is poised to hit -0.50 in the next quarter and is forecasted to reach -1.88 in one year’s time.
Technical Analysis of Larimar Therapeutics Inc (LRMR)
The latest stats from [Larimar Therapeutics Inc, LRMR] show that its last 5-days average volume of 1.01 million was inferior to 1.5 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 73.63%.
During the past 100 days, Larimar Therapeutics Inc’s (LRMR) raw stochastic average was set at 28.19%, which indicates a significant decrease from 60.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.25 in the past 14 days, which was lower than the 0.33 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.86, while its 200-day Moving Average is $3.23. Now, the first resistance to watch is $3.85. This is followed by the second major resistance level at $3.96. The third major resistance level sits at $4.02. If the price goes on to break the first support level at $3.68, it is likely to go to the next support level at $3.62. The third support level lies at $3.51 if the price breaches the second support level.
Larimar Therapeutics Inc (NASDAQ: LRMR) Key Stats
There are currently 82,778K shares outstanding in the company with a market cap of 320.10 million. Presently, the company’s annual sales total 0 K according to its annual income of -80,600 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -47,710 K.
